Vote Scores

Home / Companies / Amedisys, Inc. / 30 Dec 2024

Meeting · year to 30 June 2025417 filers reporting

Amedisys, Inc.: meeting of 30 Dec 2024

Votes reported on Form N-PX, item by item

417 Form N-PX filers reported votes at the Amedisys, Inc. meeting of 30 Dec 2024. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

9 nominees; 95.4% of reported votes for; 9 filers withheld from or voted against at least one nominee.

2,260 vote records from 123 filers. 1 of the 123 filers that marked the item either way voted against management.

99.2% for0.0% against0.8% other0.8% against management123 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

593 vote records from 414 filers. 90 of the 391 filers that marked the item either way voted against management. 23 filers reported this item without a management mark.

72.0% for21.7% against6.3% other23.0% against management414 filers91.1% for8.6% against0.3% other8.7% against management23,744,928 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

252 vote records from 123 filers. 2 of the 123 filers that marked the item either way voted against management.

98.4% for0.8% against0.8% other1.6% against management123 filers99.9% for0.0% against0.1% other0.1% against management9,763,741 reported shares

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
DimensionalForAgainst *For
State Street and SPDRForForFor
American CenturyForForFor
Franklin TempletonNo reportForNo report
InvescoForAgainst *For
EquitableForForFor
Charles SchwabForForFor
Nuveen and TIAAForForFor
ProShares and ProFundsForForFor
John Hancock and ManulifeForForFor
Morgan Stanley, Eaton Vance and CalvertForForFor
J.P. MorganForForFor
Goldman SachsNo reportForNo report
WisdomTreeForForFor
PGIM and PrudentialForAgainst *For
Jackson National fundsForForFor
Northern Trust and FlexSharesForForFor
SEIForAgainst *For
T. Rowe PriceForForFor
ThriventForForFor
Lincoln FinancialForForFor
VoyaForForFor
First TrustForForFor
Russell InvestmentsNo reportAgainst *No report
NationwideForForFor
Victory CapitalForForFor
Brighthouse FundsForForFor
Guggenheim and RydexForForFor
Columbia ThreadneedleForForFor
BNY MellonForForFor
PrincipalForForFor
Capital Group and American FundsNo reportSplit or no voteNo report
Pacific Life fundsForForFor
Global XForAgainst *For
Federated HermesForAgainst *For
AllianceBernsteinForForFor
PIMCOForForFor
AllspringNo reportForNo report
MassMutualNo reportForNo report
Janus HendersonNo reportForNo report
Neuberger BermanForForFor
Natixis and Loomis SaylesNo reportAgainst *No report
BairdNo reportForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Amedisys, Inc. meeting?

417 Form N-PX filers reported votes at the meeting of 30 Dec 2024. On say-on-pay, 90 of 391 voted against management (23.0%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Amedisys, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Amedisys, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Amedisys, Inc. with a meeting date within three days of 30 Dec 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.